BioXgen Holdings, Inc. has recently submitted a progress update, signaling important ongoing developments within the company. This filing is crucial as it demonstrates BioXgen's commitment to keeping stakeholders informed about its business activities.
BioXgen Holdings, Inc. is a company based in Tucson, Arizona. It operates in the biotechnology sector, focusing on innovative solutions in health and medicine. The company has been active in filing various reports with the SEC, including recent submissions on October 23, 2026, and October 15, 2026.
The latest filing, dated October 23, 2026, is categorized as a C-U form, which is used for progress updates. The document indicates that there is ongoing progress in the company's operations, although specific details were not available in the SEC filing.
This update may affect various stakeholders, including investors, employees, and partners, who are keen to understand the direction BioXgen is taking. The biotechnology industry, in general, may also be impacted as companies like BioXgen navigate their business developments and share updates with the public.
The filing does not say what happens next, leaving stakeholders to await further updates from the company.
Company Information
BioXgen Holdings, Inc. is incorporated in Delaware and has its business address at 5590 E. River Road, Suite 150, Tucson, AZ 85750. The company can be reached at the phone number 520-800-8229. The firm operates under the Central Index Key (CIK) number 0002103503, which is associated with its filings with the SEC.
Filing Details
The recent C-U filing was accepted on October 23, 2026, at 14:07:23. The filing includes one document, which is available in multiple formats, including HTML and XML. The complete submission text file for this filing is also accessible, providing stakeholders with additional context regarding the company's progress.
Financial Information
BioXgen Holdings has an Employer Identification Number (EIN) of 392756370, and its fiscal year ends on December 31. The company is categorized under the Securities Act of 1933, with a file number of 020-36737 and a film number of 261481729.
Despite the recent filing, specific operational progress details were not disclosed, leaving stakeholders eager for more comprehensive updates in the future.